脑小血管病研究进展

doi:10.3969/j.issn.1673-5765.2017.02.009

摘要/Abstract

摘要：

近年来，随着人口老龄化的加剧，脑小血管病（cerebral small vessel disease，CSVD）也日益增多。CSVD可引起一系列病理学、神经影像学变化及相关临床症状，是导致老年人认知功能下降和功能缺失的一大原因，本文就近年来CSVD在病理学、临床和影像学特征及诊疗方面的研究进展进行综述，以期为其进一步研究提供思路。

文章导读： 随着许多针对CSVD病理、临床特点等多层次、多方位研究的开展以及影像技术的革新，CSVD在不远的将来可实现有效的可防可控。

关键词: 脑小血管病; 病理学; 神经影像学; 临床特征; 治疗

Abstract:

Recently, the amount of cerebral small vessel disease (CSVD) has enormously increased along with the aging population. CSVD could cause a range of pathologies and neuroimaging changes, and associated clinical manifestations, which is a major cause for cognitive decline and functional loss in the elderly. This paper reviewed the research of CSVD in recent years in pathologies, clinical and imaging, diagnosis and therapeutics, so as to provide ideas for further research.

Key words: Cerebral small vessel disease; Pathologies; Neuroimaging; Clinical characteristics; Therapeutics

陶雯，柯开富. 脑小血管病研究进展[J]. 中国卒中杂志, 2017, 12(02): 147-151.

TAO Wen, KE Kai-Fu. Research Progress of Cerebral Small Vessel Disease[J]. Chinese Journal of Stroke, 2017, 12(02): 147-151.

参考文献

1 Thompson CS，Hakim AM. Living beyond our

physiological means：small vessel disease of the brain

is an expression of a systemic failure in arteriolar

function：a unifying hypothesis[J]. Stroke，2009，40：

e322-e330.

2 Pantoni L. Cerebral small vessel disease：from

pathogenesis and clinical characteristics to therapeutic

challenges[J]. Lancet Neurol，2010，9：689-701.

3 Dichgans M. Genetics of ischaemic stroke[J]. Lancet

Neurol，2007，6：149-161.

4 Ballabio E，Bersano A，Bresolin N，et al. Monogenic

vessel diseases related to ischemic stroke：a clinical

approach[J]. J Cereb Blood Flow Metab，2007，27：

1649-1662.

5 Wa rdlaw JM，Smi th EE，Bies sels GJ，e t a l .

Neuroimaging standards for research into small

vessel disease and its contribution to ageing and

neurodegeneration[J]. Lancet Neurol，2013，12：822-

838.

6 Keir SL，Wardlaw JM，Bastin ME，et al. In which

patients is diffusion-weighted magnetic resonance

imaging most useful in routine stroke care?[J]. J

Neuroimaging，2004，14：118-122.

7 Benjamin P，Viessmann O，Mackinnon AD，et al. 7

Tesla MRI in cerebral small vessel disease[J]. Int J

Stroke，2015，10：659-664.

8 Patel B，Markus HS. Magnetic resonance imaging in

cerebral small vessel disease and its use as a surrogate

disease marker[J]. Int J Stroke，2011，6：47-59.

9 van Veluw SJ，Jolink WM，Hendrikse J，et al.

Cortical microinfarcts on 7T MRI in patients with

spontaneous intracerebral hemorrhage[J]. J Cereb

Blood Flow Metab，2014，34：1104-1106.

10 Madai VI，von Samson-Himmelstjerna FC，Bauer M，

et al. Ultrahigh-field MRI in human ischemic stroke

--a 7 tesla study[J]. PLoS One，2012，7：e37631.

11 Theysohn JM，Kraff O，Maderwald S，et al. 7 tesla

MRI of microbleeds and white matter lesions as seen

in vascular dementia[J]. J Magn Reson Imaging，2011，

33：782-791.

12 Sudlow CL，Warlow CP. Comparable studies of the

incidence of stroke and its pathological types：results

from an international collaboration. International

Stroke Incidence Collaboration[J]. Stroke，1997，28：

491-499.

13 O'Sullivan M，Mor r is RG，Markus HS. Br ief

cognitive assessment for patients with cerebral small

vessel disease[J]. J Neurol Neurosurg Psychiatry，

2005，76：1140-1145.

14 Koga H，Takashima Y，Murakawa R，et al. Cognitive

consequences of multiple lacunes and leukoaraiosis as

vascular cognitive impairment in community-dwelling

elderly individuals[J]. J Stroke Cerebrovasc Dis，2009，

18：32-37.

15 Yakushiji Y，Nishiyama M，Yakushiji S，et al. Brain

microbleeds and global cognitive function in adults

without neurological disorder[J]. Stroke，2008，39：

3323-3328.

16 Pantoni L，Poggesi A，Inzitari D. The relation

between white-matter lesions and cognition[J]. Curr

Opin Neurol，2007，20：390-397.

17 LADIS Study Group. 2001-2011：a decade of the

LADIS (Leukoaraiosis And Disability) Study：what

have we learned about white matter changes and

small-vessel disease?[J]. Cerebrovasc Dis，2011，32：

577-588.

18 Jokinen H，Kalska H，Ylikoski R，et al. Longitudinal

cognitive decline in subcortical ischemic vascular

disease--the LADIS Study[J]. Cerebrovasc Dis，2009，

27：384-391.

19 Yamaguchi Y，Wada M，Sato H，et al. Impact of

ambulatory blood pressure variability on cerebral

small vessel disease progression and cognitive decline

in community-based elderly Japanese[J]. Am J

Hypertens，2014，27：1257-1267.

20 Rothwell PM，Howard SC，Dolan E，et al. Effects of

beta blockers and calcium-channel blockers on withinindividual

variability in blood pressure and risk of

stroke[J]. Lancet Neurol，2010，9：469-480.

21 Rothwell PM. Limitations of the usual blood-pressure

hypothesis and importance of variability，instability，

and episodic hypertension[J]. Lancet，2010，375：938-

948.

22 Gorelick PB，Scuteri A，Black SE，et al. Vascular

contributions to cognitive impairment and dementia：

a statement for healthcare professionals from the

Amer ican Heart Association/Amer ican Stroke

Association[J]. Stroke，2011，42：2672-2713.

能下降[29]。

CSVD发病隐匿且临床表现多种多样不易

识别，伴随人口老龄化问题，CSVD导致许多

老年人出现认知、精神和肢体功能障碍，发病

率呈上升趋势，随着医学诊疗水平的不断发展

和人群健康意识的不断提高，早期发现并防治

CSVD意义重大。

中国卒中杂志 2017年２月第12卷第２期 151

23 Neumann-Haefelin T，Hoelig S，Berkefeld J，et

al. Leukoaraiosis is a risk factor for symptomatic

intracerebral hemorrhage after thrombolysis for acute

stroke[J]. Stroke，2006，37：2463-2466.

24 Pantoni L，Fierini F，Poggesi A. Thrombolysis in

acute stroke patients with cerebral small vessel

disease[J]. Cerebrovasc Dis，2014，37：5-13.

25 Uchiyama S. Results of the Cilostazol St roke

Prevention Study Ⅱ (CSPS Ⅱ)：a randomized

controlled trial for the comparison of cilostazol and

aspirin in stroke patients[J]. Rinsho Shinkeigaku，

2010，50：832-834.

26 Kav i r ajan H，Sch nei d e r LS. Ef f i c a c y a nd

adverse effects of cholinesterase inhibitors and

memantine in vascular dementia：a meta-analysis

of randomised controlled trials[J]. Lancet Neurol，

2007，6：782-792.

27 Auchus AP，Brashear HR，Salloway S，et a l.

Galantamine treatment of vascular dementia：a

randomized trial[J]. Neurology，2007，69：448-458.

28 Wilcock G，Möbius HJ，Stöffler A. A double-blind，

placebo-controlled multicentre study of memantine

in mild to moderate vascular dementia (MMM500)[J].

Int Clin Psychopharmacol，2002，17：297-305.

29 Pantoni L，del Ser T，Soglian AG，et al. Efficacy and

safety of nimodipine in subcortical vascular dementia：

a randomized placebo-controlled trial[J]. Stroke，

2005，36：619-624.

[1]	曹黎明, 任力杰. 急性缺血性卒中诊疗技术的进展与展望[J]. 中国卒中杂志, 2024, 19(9): 983-989.
[2]	符鹏程, 曹黎明, 朱佳倩, 赵桂玉, 徐格林. 大动脉粥样硬化性缺血性卒中再灌注治疗的研究进展[J]. 中国卒中杂志, 2024, 19(9): 1004-1011.
[3]	张丽苹, 曹黎明, 肖楠, 廖雨琦, 池枫, 余艳妮, 任力杰. 纳米材料在缺血性卒中诊疗中的研究进展及挑战[J]. 中国卒中杂志, 2024, 19(9): 1012-1017.
[4]	阿娜古丽·阿不拉尼压孜, 吴晓欣, 李骄星, 李竹浩, 盛文利. 急性缺血性卒中磁敏感血管征影响因素及临床应用的研究进展[J]. 中国卒中杂志, 2024, 19(9): 1077-1085.
[5]	李光硕, 赵性泉. 《中国急性缺血性卒中诊治指南2023》解读[J]. 中国卒中杂志, 2024, 19(8): 956-961.
[6]	白磊鹏, 罗杰, 周思捷, 黄健辉, 梁铭钦, 赵庆顺. 肺叶楔形切除术后并发急性缺血性卒中行介入取栓治疗2例并文献回顾 [J]. 中国卒中杂志, 2024, 19(8): 962-966.
[7]	李丽君, 张宁, 陈琦, 王春雪. 主观性失眠与脑血管病慢性期功能预后的关系研究：基于多中心前瞻性研究的事后分析 [J]. 中国卒中杂志, 2024, 19(7): 815-821.
[8]	郭帅炜, 张亚南, 王硕. 血小板功能检测在神经外科止血功能评估中的现状与意义 [J]. 中国卒中杂志, 2024, 19(7): 848-853.
[9]	北京高血压防治协会, 中国卒中学会高血压预防与管理分会. 中国卒中患者高血压管理专家共识[J]. 中国卒中杂志, 2024, 19(6): 672-698.
[10]	李之明, 王孜杰, 李琦. 2024美国卒中学会Code ICH脑出血早期一体化诊治方案专家共识解读[J]. 中国卒中杂志, 2024, 19(6): 714-724.
[11]	王伊龙. 脑小血管病的诊治现状及未来探索之路[J]. 中国卒中杂志, 2024, 19(4): 363-374.
[12]	陈玮琪, 徐佳洁, 陆瑶, 王玲, 曹瑾怡, 陈鸿宾, 郭蕾, 吕琰琛, 汤晗, 王赞, 徐非凡, 颜庭梦, 应云清, 仲伟逸, 周蓉, 陆正齐, 程忻, 王伊龙, 中国卒中学会脑小血管病分会. 中国脑小血管病的神经影像学诊断标准及名词标准化定义——来自中国卒中学会的专家共识[J]. 中国卒中杂志, 2024, 19(4): 376-404.
[13]	胡琨, 管玲, 王伊龙. 不同神经心理症状与脑小血管病影像学关系的研究进展[J]. 中国卒中杂志, 2024, 19(4): 405-413.
[14]	杨营营, 王伊龙. 2013—2023年血管周围间隙相关研究的文献计量学分析[J]. 中国卒中杂志, 2024, 19(4): 414-422.
[15]	刘昱君, 刘雷媛, 徐炳东, 韩建邦, 杨冰, 丁燕, 杨英, 孟珩, 张玉生. 伴皮质下梗死和白质脑病的常染色体显性遗传性脑动脉病患者大脑中动脉闭塞血管内治疗1例并文献复习[J]. 中国卒中杂志, 2024, 19(4): 452-458.